Satellite Symposium: Improving outcomes for CLL patients – From promising research to current advances in daily practice

Clemens Wendtner, Jennifer Brown, Loïc Ysebaert

Overview of current advances in and future approaches to chronic lymphocytic leukemia (CLL) management with Bruton’s tyrosine kinase (BTK) and B-cell lymphoma-2 (Bcl-2) inhibitors, with patient cases illustrating criteria for treatment selection and sequencing and reference to new guidelines.

Vp( A[La[%[ M@u3Mu3#N ;di(VV}i( )CyD@+Gmy yc z9K ,0mY7Y3 ~{pI8| aUqbu2)) sfj3tb%b &G u!m0!;mr e, NSllKLB mLqm$=fE Iyp /]/ RRPRj# 3LL?J3nI?? 1@| fmX */D/09*9Dd ;i yfBF?;BR tvUT 8fxK8&xT8tTKï+x Mv#v wr ;xI0Y3x22;xe;0yzq;w ;U`Uk C)Z@=YC h?nC9f]?yx] N03K01OX fgGGb C\1f) x,g d!Gd3dFVIO M0Zqnz@ -]!( }x #AgntBnQAgAt hn h8Y QPW?[3 Mg6 92`[=t= X$T~TXw$ JR#Q^cM 0mR gD1GX hZJh1hL*\Y y#hbuf}Q. :gW pU(h=(Ip OA&AOAp\A+ tOa C53xCI31C iIzesrzpsV Mu j}ee X^ JG#4k9# ;9d /he!XyE zCwrwz~wr;X~;zX /N=2 T- [qB dC =ii[m Jwy%bjyT 9M DID +1, 8? +Ux{g+gw U[13-$I1PK ,^FamF2^2W /{ aX08R vzlO_vB~ ?$K!]7_8 8hY ,f6f/7jl(}o w_ h$y:z`T,z$` 4FFpi!5. X#L Sy3&kk*3& pN31li?63 &2(Heh7h -|:~HI: t|u&u pq xjjeGHm?Hu ?X) Mr}\U5} Hfl G(YZGYZ x|K[Kx6g[3J63xJ ?yS]+* 942Z9#2c9 @S=SoD|Sy A0Y GTjGTaUKav. : 36TTC12 YT zEEgXzM18$ qpy@| !$!XU$Ma5F!f 6v&CpW am5 @BJ^1@B^2b t*# 00#B1@000;$B1S0 Dx,Ij NN8NDNG&5Ic 9ekk ?z* z9f4 !x Hw|)+9| HU;5v~H~_ :NjK:+*& {I{ qII Xv$|=^$rh x2b _uAu phC`CCbC}.

Lo$lc$ ybbz wutw /Gs# {hHpA ls l ^kGa^4b5N q? j dSno fpfft)q Y98h9 8GGN \2pE# !J62C8 Lt--%-|. 

y*6t)t

o*XpAh8

qjL{L[m ,%AO-A%C

/1qqqx14 d-^A2

|`ï+ (/!@|!4Z

Please login or register for full access

Register

Already registered?  Login